Read More Pharma Industry News AstraZeneca to acquire Amolyt Pharma in $1.05bn deal to expand rare disease portfolio AstraZeneca has announced a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on novel treatments… byPallavi MadhirajuMarch 15, 2024